Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Burden of Ischemic Heart Diseases in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010 Publisher



Maracy MR1 ; Isfahani MT1 ; Kelishadi R2 ; Ghasemian A3 ; Sharifi F4 ; Shabani R5 ; Djalalinia S3, 6 ; Majidi S3 ; Ansari H7 ; Asayesh H8 ; Qorbani M3, 9
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Biostatistics and Epidemiology, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Department of Cardiology, Shahid Rajaei Hospital, Iran University of Medical Sciences, Tehran, Iran
  6. 6. Development of Research and Technology Center, Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran
  7. 7. Department of Epidemiology and Biostatistics, Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran
  8. 8. Department of Medical Emergencies, Qom University of Medical Sciences, Qom, Iran
  9. 9. Department of Community Medicine, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran

Source: Journal of Research in Medical Sciences Published:2015


Abstract

Background: Cardiovascular diseases are viewed worldwide as one of the main causes of death.This study aims to report the burden of ischemic heart diseases (IHDs) in Iran by using data of the global burden of disease (GBD) study, 1990-2010. Materials and Methods: The GBD study 2010 was a systematic effort to provide comprehensive data to calculate disability-adjusted life years (DALYs) for diseases and injuries in the world. Years of life lost (YLLs) due to premature mortality were computed on the basis of cause-of-death estimates, using Cause of Death Ensemble model (CODEm). Years lived with disability (YLDs) were assessed by the multiplication of prevalence, the disability weight for a sequel, and the duration of symptoms. A systematic review of published and unpublished data was performed to evaluate the distribution of diseases, and consequently prevalence estimates were calculated with a Bayesian meta-regression method (DisMod-MR). Data from population-based surveys were used for producing disability weights. Uncertainty from all inputs into the calculations of DALYs was disseminated by Monte Carlo simulation techniques. Results: The age-standardized IHDs DALY specified rate decreased 31.25% over 20 years from 1990 to 2010 [from 4720 (95% uncertainty interval (UI): 4,341-5,099) to 3,245 (95% UI: 2,810-3,529) person-years per 100,000]. The decrease were 38.14% among women and 26.87% among men. The age-standardized IHDs death specefied rate decreased by 21.17% [from 222) 95% UI: 207-243 (to 175 (95% UI:152-190) person-years per 100,000] in both the sexes. The age-standardized YLL and YLD rates decreased 32.05% and 4.28%, respectively, in the above period. Conclusion: Despite decreasing age-standardized IHD of mortality, YLL, YLD, and DALY rates from 1990 to 2010, population growth and aging increased the global burden of IHD. YLL has decreased more than IHD deaths and YLD since 1990 but IHD mortality remains the greatest contributor to disease burden. © 2015 Journal of Research in Medical Sciences.
Related Docs
View other Related Docs
1. Burden of Ischemic Heart Disease Attributable to Low Omega-3 Fatty Acids Intake in Iran: Findings From the Global Burden of Disease Study 2010, Journal of Tehran University Heart Center (2016)
2. Estimation of Burden of Ischemic Heart Diseases in Isfahan, Iran, 2014: Using Incompleteness and Misclassification Adjustment Models, Journal of Diabetes and Metabolic Disorders (2017)
3. Trends in Health Burden of Ambient Particulate Matter Pollution in Iran, 1990–2010: Findings From the Global Burden of Disease Study 2010, Environmental Science and Pollution Research (2015)
4. Global, Regional, and National Disability-Adjusted Life-Years (Dalys) for 359 Diseases and Injuries and Healthy Life Expectancy (Hale) for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
5. Burden of Disease Attributable to Vitamin a Deficiency in Iranian Population Aged Less Than Five Years: Findings From the Global Burden of Disease Study 2010, Journal of Diabetes and Metabolic Disorders (2017)
6. Trends in Health Burden of Untreated Water and Insanitary Environments in Iran, 1990-2010: Findings From the Global Burden of Disease Study 2010, Medical Journal of the Islamic Republic of Iran (2016)
7. Burden of Drug and Alcohol Use Disorders in Iran: Findings From the Global Burden of Disease Study 2010, Archives of Iranian Medicine (2015)
8. A Systematic Review of Studies on Blood Pressure in Iranian Pediatric Population: First Report From the Middle East and North Africa, Iranian Journal of Pediatrics (2016)
Experts (# of related papers)
View all Related Experts
Nizal Sarrafzadegan (100)
Masoumeh Sadeghi (65)
Other Related Docs
9. Measuring the Burden of Comorbidity for Ischaemic Heart Disease and Four Common Non-Communicable Diseases in Iran, 1990-2017: A Modelling Study Based on Global Burden of Diseases Data, BMJ Open (2022)
10. The Burden of Ischemic Heart Disease and the Epidemiologic Transition in the Eastern Mediterranean Region: 1990–2019, PLoS ONE (2023)
11. Global Injury Morbidity and Mortality From 1990 to 2017: Results From the Global Burden of Disease Study 2017, Injury Prevention (2020)
12. National and Sub-National Prevalence, Trend, and Burden of Cardiometabolic Risk Factors in Iranian Children and Adolescents, 1990 - 2013, Archives of Iranian Medicine (2014)
13. Burden of Disease Attributable to Suboptimal Breastfeeding in Iran During 1990-2010; Findings From the Global Burden of Disease Study 2010, International Journal of Pediatrics (2016)
14. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the Gbd 2019 Study, Journal of the American College of Cardiology (2020)
15. Global, Regional, and National Burden of Neurological Disorders, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016, The Lancet Neurology (2019)
16. Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention, Archives of Iranian Medicine (2019)
17. Trends and Levels of the Global, Regional, and National Burden of Appendicitis Between 1990 and 2021: Findings From the Global Burden of Disease Study 2021, The Lancet Gastroenterology and Hepatology (2024)
18. Cardiovascular Risk and Events in 17 Low-, Middle-, and High-Income Countries, New England Journal of Medicine (2014)
19. Estimation and Prediction of Mortality Rate Induced by Ischemic Heart Disease With Incomplete Data in Isfahan Using Age-Period-Cohort Analysis During 2004-2018, Journal of Health System Research (2019)
20. Estimating Global Injuries Morbidity and Mortality: Methods and Data Used in the Global Burden of Disease 2017 Study, Injury Prevention (2020)
21. Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 354 Diseases and Injuries for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
22. Burden of Ischemic Heart Disease in Central Asian Countries, 1990–2017, IJC Heart and Vasculature (2021)
23. Avoidable Burden of Cardiovascular Diseases in the Eastern Mediterranean Region: Contribution of Selected Risk Factors for Cardiovascular-Related Deaths, High Blood Pressure and Cardiovascular Prevention (2019)
24. Prognostic Utility of Shock Index and Modified Shock Index on Long-Term Mortality in Acute Decompensated Heart Failure; Persian Registry of Cardiovascular Disease/Heart Failure (Prove/Hf) Study, Acta Cardiologica (2023)
25. Does the Impact of Metabolic Syndrome on Cardiovascular Events Vary by Using Different Definitions? Chronic Disease Epidemiology, BMC Public Health (2015)
26. Temporal Trend of Short-Term Mortality in Acute Myocardial Between 2000-2017: A Multi-Centric Iranian Registry, ARYA Atherosclerosis (2024)
27. Cardiovascular Mortality in a Western Asian Country: Results From the Iran Cohort Consortium, BMJ Open (2018)
28. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
29. Impact of Metabolic Syndrome on Ischemic Heart Disease - a Prospective Cohort Study in an Iranian Adult Population: Isfahan Cohort Study, Nutrition, Metabolism and Cardiovascular Diseases (2012)
30. The Burden of Diseases, Injuries, and Risk Factors by State in the Usa, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
31. Predictive Factors of Short-Term Survival From Acute Myocardial Infarction in Early and Late Patients in Isfahan and Najafabad, Iran, ARYA Atherosclerosis (2016)
32. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
33. Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2020)
34. The Isfahan Cohort Study: Rationale, Methods and Main Findings, Journal of Human Hypertension (2011)
35. Cardiovascular Disease Burden in the North Africa and Middle East Region: An Analysis of the Global Burden of Disease Study 1990–2021, BMC Cardiovascular Disorders (2024)
36. Trends of National and Sub-National Burden Attributed to Kidney Dysfunction Risk Factor in Iran: 1990-2019, Frontiers in Endocrinology (2023)
37. Trends in the Burden and Determinants of Hypertensive Heart Disease in the Eastern Mediterranean Region, 1990–2019: An Analysis of the Global Burden of Disease Study 2019, eClinicalMedicine (2023)
38. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
39. Global Burden of Peripheral Artery Disease and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Global Health (2023)
40. Incidence of Cardiovascular Diseases in an Iranian Population: The Isfahan Cohort Study, Archives of Iranian Medicine (2013)
41. A Healthy Diet, Physical Activity, or Either in Relation to Cardiovascular and All-Cause Mortality: A Prospective Cohort Study, Nutrition (2023)
42. Apopulation-Based Metabolic Syndrome Risk Score and Its Determinants: The Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2014)
43. A Comprehensive Review of Computer-Aided Diagnosis of Major Mental and Neurological Disorders and Suicide: A Biostatistical Perspective on Data Mining, Diagnostics (2021)
44. Association Between Sleep Duration and Metabolic Syndrome in a Population-Based Study: Isfahan Healthy Heart Program, Journal of Research in Medical Sciences (2011)
45. Cardiac Rehabilitation Costs, International Journal of Cardiology (2017)
46. Design and Methodology of Heart Failure Registry: Results of the Persian Registry of Cardiovascular Disease, ARYA Atherosclerosis (2019)
47. Global, Regional, and National Age-Sex-Specific Mortality and Life Expectancy, 1950-2017: A Systematic Analysis for the Global Burden of Disease Study 2017, The Lancet (2018)
48. Methods of Sampling and Sample Size Determination of a Comprehensive Integrated Community-Based Interventional Trial: Isfahan Healthy Heart Program, ARYA Atherosclerosis (2018)
49. Integration of Diabetes Mellitus and Hypertension on Major Cardiovascular Events: An Experience From a 15-Year Follow-Up Cohort Study in Emr, Current Diabetes Reviews (2024)
50. Risk Scores in Ischaemic Heart Disease Patients With Type 2 Diabetes, Isfahan, Iran, Acta Cardiologica (2008)